img

Global CD98 Antibody Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CD98 Antibody Market Insights, Forecast to 2034

CD98 Antibody (E-5) is a mouse monoclonal IgG1 κ CD98 antibody, cited in 18 publications, provided at 200 µg/ml. raised against amino acids 230-529 of CD98 of human origin. CD98 Antibody (E-5) is recommended for detection of CD98 of human origin by WB, IP, IF, IHC(P) and ELISA.
Market Analysis and InsightsGlobal CD98 Antibody Market
Global CD98 Antibody market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, CD98 Antibody industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, CD98 Antibody key companies include Merck, Thermo Fisher Scientific, Bioss, Proteintech Group, Aviva Systems Biology, Leading Biology, RayBiotech, ABclonal Technology and OriGene Technologies, etc. Merck, Thermo Fisher Scientific, Bioss are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of CD98 Antibody were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole CD98 Antibody market and estimated to attract more attentions from industry insiders and investors.
CD98 Antibody can be divided into Monoclonal and Polyclonal, etc. Monoclonal is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
CD98 Antibody is widely used in various fields, such as Immunochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP) and Western Blot (WB), etc. Immunochemistry (IHC) provides greatest supports to the CD98 Antibody industry development. In 2022, global % revenue of CD98 Antibody went into Immunochemistry (IHC) filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global CD98 Antibody market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global CD98 Antibody market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck
Thermo Fisher Scientific
Bioss
Proteintech Group
Aviva Systems Biology
Leading Biology
RayBiotech
ABclonal Technology
OriGene Technologies
Novus Biologicals
R&D Systems
AssayPro
Abnova Corporation
Sino Biological
Biomatik
CUSABIO Technology
Affinity Biosciences
Creative Biolabs
Jingjie PTM BioLab
Beijing Solarbio
Segment by Type
Monoclonal
Polyclonal

Segment by Application


Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, CD98 Antibody introduction, etc. CD98 Antibody Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of CD98 Antibody
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD98 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global CD98 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CD98 Antibody Market Perspective (2018-2033)
2.2 Global CD98 Antibody Growth Trends by Region
2.2.1 CD98 Antibody Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CD98 Antibody Historic Market Size by Region (2018-2023)
2.2.3 CD98 Antibody Forecasted Market Size by Region (2024-2033)
2.3 CD98 Antibody Market Dynamics
2.3.1 CD98 Antibody Industry Trends
2.3.2 CD98 Antibody Market Drivers
2.3.3 CD98 Antibody Market Challenges
2.3.4 CD98 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue CD98 Antibody by Players
3.1.1 Global CD98 Antibody Revenue by Players (2018-2023)
3.1.2 Global CD98 Antibody Revenue Market Share by Players (2018-2023)
3.2 Global CD98 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of CD98 Antibody, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global CD98 Antibody Market Concentration Ratio
3.4.1 Global CD98 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD98 Antibody Revenue in 2022
3.5 Global Key Players of CD98 Antibody Head office and Area Served
3.6 Global Key Players of CD98 Antibody, Product and Application
3.7 Global Key Players of CD98 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CD98 Antibody Breakdown Data by Type
4.1 Global CD98 Antibody Historic Market Size by Type (2018-2023)
4.2 Global CD98 Antibody Forecasted Market Size by Type (2024-2033)
5 CD98 Antibody Breakdown Data by Application
5.1 Global CD98 Antibody Historic Market Size by Application (2018-2023)
5.2 Global CD98 Antibody Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CD98 Antibody Market Size (2018-2033)
6.2 North America CD98 Antibody Market Size by Type
6.2.1 North America CD98 Antibody Market Size by Type (2018-2023)
6.2.2 North America CD98 Antibody Market Size by Type (2024-2033)
6.2.3 North America CD98 Antibody Market Share by Type (2018-2033)
6.3 North America CD98 Antibody Market Size by Application
6.3.1 North America CD98 Antibody Market Size by Application (2018-2023)
6.3.2 North America CD98 Antibody Market Size by Application (2024-2033)
6.3.3 North America CD98 Antibody Market Share by Application (2018-2033)
6.4 North America CD98 Antibody Market Size by Country
6.4.1 North America CD98 Antibody Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America CD98 Antibody Market Size by Country (2018-2023)
6.4.3 North America CD98 Antibody Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe CD98 Antibody Market Size (2018-2033)
7.2 Europe CD98 Antibody Market Size by Type
7.2.1 Europe CD98 Antibody Market Size by Type (2018-2023)
7.2.2 Europe CD98 Antibody Market Size by Type (2024-2033)
7.2.3 Europe CD98 Antibody Market Share by Type (2018-2033)
7.3 Europe CD98 Antibody Market Size by Application
7.3.1 Europe CD98 Antibody Market Size by Application (2018-2023)
7.3.2 Europe CD98 Antibody Market Size by Application (2024-2033)
7.3.3 Europe CD98 Antibody Market Share by Application (2018-2033)
7.4 Europe CD98 Antibody Market Size by Country
7.4.1 Europe CD98 Antibody Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe CD98 Antibody Market Size by Country (2018-2023)
7.4.3 Europe CD98 Antibody Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China CD98 Antibody Market Size (2018-2033)
8.2 China CD98 Antibody Market Size by Type
8.2.1 China CD98 Antibody Market Size by Type (2018-2023)
8.2.2 China CD98 Antibody Market Size by Type (2024-2033)
8.2.3 China CD98 Antibody Market Share by Type (2018-2033)
8.3 China CD98 Antibody Market Size by Application
8.3.1 China CD98 Antibody Market Size by Application (2018-2023)
8.3.2 China CD98 Antibody Market Size by Application (2024-2033)
8.3.3 China CD98 Antibody Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia CD98 Antibody Market Size (2018-2033)
9.2 Asia CD98 Antibody Market Size by Type
9.2.1 Asia CD98 Antibody Market Size by Type (2018-2023)
9.2.2 Asia CD98 Antibody Market Size by Type (2024-2033)
9.2.3 Asia CD98 Antibody Market Share by Type (2018-2033)
9.3 Asia CD98 Antibody Market Size by Application
9.3.1 Asia CD98 Antibody Market Size by Application (2018-2023)
9.3.2 Asia CD98 Antibody Market Size by Application (2024-2033)
9.3.3 Asia CD98 Antibody Market Share by Application (2018-2033)
9.4 Asia CD98 Antibody Market Size by Region
9.4.1 Asia CD98 Antibody Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia CD98 Antibody Market Size by Region (2018-2023)
9.4.3 Asia CD98 Antibody Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America CD98 Antibody Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America CD98 Antibody Market Size by Type
10.2.1 Middle East, Africa, and Latin America CD98 Antibody Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America CD98 Antibody Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America CD98 Antibody Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America CD98 Antibody Market Size by Application
10.3.1 Middle East, Africa, and Latin America CD98 Antibody Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America CD98 Antibody Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America CD98 Antibody Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America CD98 Antibody Market Size by Country
10.4.1 Middle East, Africa, and Latin America CD98 Antibody Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America CD98 Antibody Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America CD98 Antibody Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck CD98 Antibody Introduction
11.1.4 Merck Revenue in CD98 Antibody Business (2018-2023)
11.1.5 Merck Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific CD98 Antibody Introduction
11.2.4 Thermo Fisher Scientific Revenue in CD98 Antibody Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Bioss
11.3.1 Bioss Company Details
11.3.2 Bioss Business Overview
11.3.3 Bioss CD98 Antibody Introduction
11.3.4 Bioss Revenue in CD98 Antibody Business (2018-2023)
11.3.5 Bioss Recent Developments
11.4 Proteintech Group
11.4.1 Proteintech Group Company Details
11.4.2 Proteintech Group Business Overview
11.4.3 Proteintech Group CD98 Antibody Introduction
11.4.4 Proteintech Group Revenue in CD98 Antibody Business (2018-2023)
11.4.5 Proteintech Group Recent Developments
11.5 Aviva Systems Biology
11.5.1 Aviva Systems Biology Company Details
11.5.2 Aviva Systems Biology Business Overview
11.5.3 Aviva Systems Biology CD98 Antibody Introduction
11.5.4 Aviva Systems Biology Revenue in CD98 Antibody Business (2018-2023)
11.5.5 Aviva Systems Biology Recent Developments
11.6 Leading Biology
11.6.1 Leading Biology Company Details
11.6.2 Leading Biology Business Overview
11.6.3 Leading Biology CD98 Antibody Introduction
11.6.4 Leading Biology Revenue in CD98 Antibody Business (2018-2023)
11.6.5 Leading Biology Recent Developments
11.7 RayBiotech
11.7.1 RayBiotech Company Details
11.7.2 RayBiotech Business Overview
11.7.3 RayBiotech CD98 Antibody Introduction
11.7.4 RayBiotech Revenue in CD98 Antibody Business (2018-2023)
11.7.5 RayBiotech Recent Developments
11.8 ABclonal Technology
11.8.1 ABclonal Technology Company Details
11.8.2 ABclonal Technology Business Overview
11.8.3 ABclonal Technology CD98 Antibody Introduction
11.8.4 ABclonal Technology Revenue in CD98 Antibody Business (2018-2023)
11.8.5 ABclonal Technology Recent Developments
11.9 OriGene Technologies
11.9.1 OriGene Technologies Company Details
11.9.2 OriGene Technologies Business Overview
11.9.3 OriGene Technologies CD98 Antibody Introduction
11.9.4 OriGene Technologies Revenue in CD98 Antibody Business (2018-2023)
11.9.5 OriGene Technologies Recent Developments
11.10 Novus Biologicals
11.10.1 Novus Biologicals Company Details
11.10.2 Novus Biologicals Business Overview
11.10.3 Novus Biologicals CD98 Antibody Introduction
11.10.4 Novus Biologicals Revenue in CD98 Antibody Business (2018-2023)
11.10.5 Novus Biologicals Recent Developments
11.11 R&D Systems
11.11.1 R&D Systems Company Details
11.11.2 R&D Systems Business Overview
11.11.3 R&D Systems CD98 Antibody Introduction
11.11.4 R&D Systems Revenue in CD98 Antibody Business (2018-2023)
11.11.5 R&D Systems Recent Developments
11.12 AssayPro
11.12.1 AssayPro Company Details
11.12.2 AssayPro Business Overview
11.12.3 AssayPro CD98 Antibody Introduction
11.12.4 AssayPro Revenue in CD98 Antibody Business (2018-2023)
11.12.5 AssayPro Recent Developments
11.13 Abnova Corporation
11.13.1 Abnova Corporation Company Details
11.13.2 Abnova Corporation Business Overview
11.13.3 Abnova Corporation CD98 Antibody Introduction
11.13.4 Abnova Corporation Revenue in CD98 Antibody Business (2018-2023)
11.13.5 Abnova Corporation Recent Developments
11.14 Sino Biological
11.14.1 Sino Biological Company Details
11.14.2 Sino Biological Business Overview
11.14.3 Sino Biological CD98 Antibody Introduction
11.14.4 Sino Biological Revenue in CD98 Antibody Business (2018-2023)
11.14.5 Sino Biological Recent Developments
11.15 Biomatik
11.15.1 Biomatik Company Details
11.15.2 Biomatik Business Overview
11.15.3 Biomatik CD98 Antibody Introduction
11.15.4 Biomatik Revenue in CD98 Antibody Business (2018-2023)
11.15.5 Biomatik Recent Developments
11.16 CUSABIO Technology
11.16.1 CUSABIO Technology Company Details
11.16.2 CUSABIO Technology Business Overview
11.16.3 CUSABIO Technology CD98 Antibody Introduction
11.16.4 CUSABIO Technology Revenue in CD98 Antibody Business (2018-2023)
11.16.5 CUSABIO Technology Recent Developments
11.17 Affinity Biosciences
11.17.1 Affinity Biosciences Company Details
11.17.2 Affinity Biosciences Business Overview
11.17.3 Affinity Biosciences CD98 Antibody Introduction
11.17.4 Affinity Biosciences Revenue in CD98 Antibody Business (2018-2023)
11.17.5 Affinity Biosciences Recent Developments
11.18 Creative Biolabs
11.18.1 Creative Biolabs Company Details
11.18.2 Creative Biolabs Business Overview
11.18.3 Creative Biolabs CD98 Antibody Introduction
11.18.4 Creative Biolabs Revenue in CD98 Antibody Business (2018-2023)
11.18.5 Creative Biolabs Recent Developments
11.19 Jingjie PTM BioLab
11.19.1 Jingjie PTM BioLab Company Details
11.19.2 Jingjie PTM BioLab Business Overview
11.19.3 Jingjie PTM BioLab CD98 Antibody Introduction
11.19.4 Jingjie PTM BioLab Revenue in CD98 Antibody Business (2018-2023)
11.19.5 Jingjie PTM BioLab Recent Developments
11.20 Beijing Solarbio
11.20.1 Beijing Solarbio Company Details
11.20.2 Beijing Solarbio Business Overview
11.20.3 Beijing Solarbio CD98 Antibody Introduction
11.20.4 Beijing Solarbio Revenue in CD98 Antibody Business (2018-2023)
11.20.5 Beijing Solarbio Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CD98 Antibody Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global CD98 Antibody Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global CD98 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global CD98 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global CD98 Antibody Market Share by Region (2018-2023)
Table 8. Global CD98 Antibody Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global CD98 Antibody Market Share by Region (2024-2033)
Table 10. CD98 Antibody Market Trends
Table 11. CD98 Antibody Market Drivers
Table 12. CD98 Antibody Market Challenges
Table 13. CD98 Antibody Market Restraints
Table 14. Global CD98 Antibody Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global CD98 Antibody Revenue Share by Players (2018-2023)
Table 16. Global Top CD98 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD98 Antibody as of 2022)
Table 17. Global CD98 Antibody Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by CD98 Antibody Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of CD98 Antibody, Headquarters and Area Served
Table 20. Global Key Players of CD98 Antibody, Product and Application
Table 21. Global Key Players of CD98 Antibody, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CD98 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global CD98 Antibody Revenue Market Share by Type (2018-2023)
Table 25. Global CD98 Antibody Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global CD98 Antibody Revenue Market Share by Type (2024-2033)
Table 27. Global CD98 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global CD98 Antibody Revenue Share by Application (2018-2023)
Table 29. Global CD98 Antibody Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global CD98 Antibody Revenue Share by Application (2024-2033)
Table 31. North America CD98 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America CD98 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America CD98 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America CD98 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America CD98 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America CD98 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America CD98 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe CD98 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe CD98 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe CD98 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe CD98 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe CD98 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe CD98 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe CD98 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 45. China CD98 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 46. China CD98 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 47. China CD98 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 48. China CD98 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia CD98 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia CD98 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia CD98 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia CD98 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia CD98 Antibody Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia CD98 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia CD98 Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America CD98 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America CD98 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America CD98 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America CD98 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America CD98 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America CD98 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America CD98 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck CD98 Antibody Product
Table 66. Merck Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 67. Merck Recent Developments
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific CD98 Antibody Product
Table 71. Thermo Fisher Scientific Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Developments
Table 73. Bioss Company Details
Table 74. Bioss Business Overview
Table 75. Bioss CD98 Antibody Product
Table 76. Bioss Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 77. Bioss Recent Developments
Table 78. Proteintech Group Company Details
Table 79. Proteintech Group Business Overview
Table 80. Proteintech Group CD98 Antibody Product
Table 81. Proteintech Group Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 82. Proteintech Group Recent Developments
Table 83. Aviva Systems Biology Company Details
Table 84. Aviva Systems Biology Business Overview
Table 85. Aviva Systems Biology CD98 Antibody Product
Table 86. Aviva Systems Biology Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 87. Aviva Systems Biology Recent Developments
Table 88. Leading Biology Company Details
Table 89. Leading Biology Business Overview
Table 90. Leading Biology CD98 Antibody Product
Table 91. Leading Biology Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 92. Leading Biology Recent Developments
Table 93. RayBiotech Company Details
Table 94. RayBiotech Business Overview
Table 95. RayBiotech CD98 Antibody Product
Table 96. RayBiotech Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 97. RayBiotech Recent Developments
Table 98. ABclonal Technology Company Details
Table 99. ABclonal Technology Business Overview
Table 100. ABclonal Technology CD98 Antibody Product
Table 101. ABclonal Technology Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 102. ABclonal Technology Recent Developments
Table 103. OriGene Technologies Company Details
Table 104. OriGene Technologies Business Overview
Table 105. OriGene Technologies CD98 Antibody Product
Table 106. OriGene Technologies Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 107. OriGene Technologies Recent Developments
Table 108. Novus Biologicals Company Details
Table 109. Novus Biologicals Business Overview
Table 110. Novus Biologicals CD98 Antibody Product
Table 111. Novus Biologicals Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 112. Novus Biologicals Recent Developments
Table 113. R&D Systems Company Details
Table 114. R&D Systems Business Overview
Table 115. R&D Systems CD98 Antibody Product
Table 116. R&D Systems Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 117. R&D Systems Recent Developments
Table 118. AssayPro Company Details
Table 119. AssayPro Business Overview
Table 120. AssayPro CD98 Antibody Product
Table 121. AssayPro Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 122. AssayPro Recent Developments
Table 123. Abnova Corporation Company Details
Table 124. Abnova Corporation Business Overview
Table 125. Abnova Corporation CD98 Antibody Product
Table 126. Abnova Corporation Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 127. Abnova Corporation Recent Developments
Table 128. Sino Biological Company Details
Table 129. Sino Biological Business Overview
Table 130. Sino Biological CD98 Antibody Product
Table 131. Sino Biological Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 132. Sino Biological Recent Developments
Table 133. Biomatik Company Details
Table 134. Biomatik Business Overview
Table 135. Biomatik CD98 Antibody Product
Table 136. Biomatik Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 137. Biomatik Recent Developments
Table 138. CUSABIO Technology Company Details
Table 139. CUSABIO Technology Business Overview
Table 140. CUSABIO Technology CD98 Antibody Product
Table 141. CUSABIO Technology Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 142. CUSABIO Technology Recent Developments
Table 143. Affinity Biosciences Company Details
Table 144. Affinity Biosciences Business Overview
Table 145. Affinity Biosciences CD98 Antibody Product
Table 146. Affinity Biosciences Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 147. Affinity Biosciences Recent Developments
Table 148. Creative Biolabs Company Details
Table 149. Creative Biolabs Business Overview
Table 150. Creative Biolabs CD98 Antibody Product
Table 151. Creative Biolabs Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 152. Creative Biolabs Recent Developments
Table 153. Jingjie PTM BioLab Company Details
Table 154. Jingjie PTM BioLab Business Overview
Table 155. Jingjie PTM BioLab CD98 Antibody Product
Table 156. Jingjie PTM BioLab Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 157. Jingjie PTM BioLab Recent Developments
Table 158. Beijing Solarbio Company Details
Table 159. Beijing Solarbio Business Overview
Table 160. Beijing Solarbio CD98 Antibody Product
Table 161. Beijing Solarbio Revenue in CD98 Antibody Business (2018-2023) & (US$ Million)
Table 162. Beijing Solarbio Recent Developments
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD98 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global CD98 Antibody Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Features
Figure 4. Polyclonal Features
Figure 5. Global CD98 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global CD98 Antibody Market Share by Application: 2022 VS 2033
Figure 7. Immunochemistry (IHC) Case Studies
Figure 8. Immunofluorescence (IF) Case Studies
Figure 9. Immunoprecipitation (IP) Case Studies
Figure 10. Western Blot (WB) Case Studies
Figure 11. ELISA Case Studies
Figure 12. Others Case Studies
Figure 13. CD98 Antibody Report Years Considered
Figure 14. Global CD98 Antibody Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global CD98 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global CD98 Antibody Market Share by Region: 2022 VS 2033
Figure 17. Global CD98 Antibody Market Share by Players in 2022
Figure 18. Global Top CD98 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD98 Antibody as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by CD98 Antibody Revenue in 2022
Figure 20. North America CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America CD98 Antibody Market Share by Type (2018-2033)
Figure 22. North America CD98 Antibody Market Share by Application (2018-2033)
Figure 23. North America CD98 Antibody Market Share by Country (2018-2033)
Figure 24. United States CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe CD98 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe CD98 Antibody Market Share by Type (2018-2033)
Figure 28. Europe CD98 Antibody Market Share by Application (2018-2033)
Figure 29. Europe CD98 Antibody Market Share by Country (2018-2033)
Figure 30. Germany CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China CD98 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China CD98 Antibody Market Share by Type (2018-2033)
Figure 38. China CD98 Antibody Market Share by Application (2018-2033)
Figure 39. Asia CD98 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia CD98 Antibody Market Share by Type (2018-2033)
Figure 41. Asia CD98 Antibody Market Share by Application (2018-2033)
Figure 42. Asia CD98 Antibody Market Share by Region (2018-2033)
Figure 43. Japan CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America CD98 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America CD98 Antibody Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America CD98 Antibody Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America CD98 Antibody Market Share by Country (2018-2033)
Figure 53. Brazil CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries CD98 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 61. Bioss Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 62. Proteintech Group Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 63. Aviva Systems Biology Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 64. Leading Biology Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 65. RayBiotech Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 66. ABclonal Technology Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 67. OriGene Technologies Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 68. Novus Biologicals Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 69. R&D Systems Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 70. AssayPro Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 71. Abnova Corporation Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 72. Sino Biological Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 73. Biomatik Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 74. CUSABIO Technology Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 75. Affinity Biosciences Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 76. Creative Biolabs Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 77. Jingjie PTM BioLab Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 78. Beijing Solarbio Revenue Growth Rate in CD98 Antibody Business (2018-2023)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed